Evaluation of Inhaled Treatment in Sinusitis

Phase 3CompletedNCT01907204

Cliniques universitaires Saint-Luc- Université Catholique de Louvain50 enrolled

Overview

The purpose of this study is to determine whether inhaled corticosteroid (specially nebulized) could be a good alternative to oral corticosteroid and whether they are effective in the treatment of sinusitis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Sinusitis

Interventions

methylprednisoloneDRUG

Oral 32mg/8d-16mg/4d-8mg/4d

BudesonideDRUG

Budesonide by metered dose inhaler

BudesonideDRUG

Budesonide by nebulization

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Nasal/Sinus polyps Exclusion Criteria: * Previous sinus surgery * Age under 18y * Use of antibiotics

Outcomes

Primary Outcomes

Sniffin' Sticks Test

Time frame: Baseline and day 15

Secondary Outcomes

Specific quality of life questionnaire (Snot 20)

Time frame: Baseline and day 15

Retro Olfaction Test

Time frame: Baseline and day 15

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.